Recurrence · people requiring intervention for short saphenous vein varices
Endovenous laser ablation showed no clear difference in clinical evidence of recurrence after 1 year compared with conventional surgery (low certainty).
1 finding from 1 review
Reintervention (due to technical failure) · people requiring intervention for short saphenous vein varices
1 finding from 1 review
Disease‐specific quality of life · people requiring intervention for short saphenous vein varices
2 findings from 1 review
Complications at 6 weeks · people requiring intervention for short saphenous vein varices
1 finding from 1 review
Recanalisation or persistence of reflux at 6 weeks · people requiring intervention for short saphenous vein varices
Ultrasound‐guided foam sclerotherapy showed no clear difference in recanalisation or persistence of reflux at 6 weeks compared with conventional surgery (low certainty).
1 finding from 1 review
Recurrence of reflux at 1 year · people requiring intervention for short saphenous vein varices
Ultrasound‐guided foam sclerotherapy showed no clear difference in recurrence of reflux at 1 year compared with conventional surgery (low certainty).
1 finding from 1 review
Intervention not reported
Successful cannulation at the first attempt · paediatric patients
The intervention probably leads to higher successful cannulation at the first attempt (moderate certainty).
1 finding from 1 review
Intervention not reported
Rate of complications (haematoma or ischaemia) · paediatric patients
The intervention probably leads to lower rate of complications (haematoma or ischaemia) (moderate certainty).
1 finding from 1 review
Intervention not reported
Successful cannulation within the first 2 attempts · paediatric patients
The intervention probably leads to higher successful cannulation within the first 2 attempts (moderate certainty).
1 finding from 1 review
Short‐term mortality · gastric cancer
Laparoscopic gastrectomy showed no clear difference in short‐term mortality compared with open gastrectomy (low certainty).
1 finding from 1 review
All‐cause mortality at maximal · gastric cancer
It is very uncertain whether laparoscopic gastrectomy changes long‐term mortality (maximal compared with open gastrectomy (very low certainty).
1 finding from 1 review
Proportion with a serious adverse event (< 3 months) · gastric cancer
It is very uncertain whether laparoscopic gastrectomy changes proportion with a serious adverse event (< 3 months) compared with open gastrectomy (very low certainty).
1 finding from 1 review
Long‐term recurrence (maximal · gastric cancer
It is very uncertain whether laparoscopic gastrectomy changes long‐term recurrence (maximal compared with open gastrectomy (very low certainty).
1 finding from 1 review
Proportion with an adverse event (< 3 months) · gastric cancer
It is very uncertain whether laparoscopic gastrectomy changes proportion with an adverse event (< 3 months) compared with open gastrectomy (very low certainty).
1 finding from 1 review
Quantity of perioperative blood transfused · gastric cancer
1 finding from 1 review
Length of hospital stay · gastric cancer
1 finding from 1 review
Lymph nodes retrieved · gastric cancer
1 finding from 1 review
Overall survival · people with advanced gastric cancer
Summary of findings: Molecular‐targeted therapy plus chemotherapy showed no clear difference in overall survival compared with chemotherapy alone (low certainty).
1 finding from 1 review
Progression‐free survival · people with advanced gastric cancer
Summary of findings: Molecular‐targeted therapy plus chemotherapy showed no clear difference in progression‐free survival compared with chemotherapy alone (low certainty).
1 finding from 1 review
Health status and quality of life · people with advanced gastric cancer
1 finding from 1 review